Low Peripheral Blood Counts and Elevated Proinflammatory Cytokines Signal a Poor CD19 Chimeric Antigen Receptor T-cell Response in Acute Lymphoblastic LeukemiaKatelyn Burleigh, Heather Gustafson, Rebecca Gardner et al.|Transplantation and Cellular Therapy|2025Cited by 3
PBMC-Humanized Mouse Model to Assess Individual Variability in Efficacy and Toxicity of Universal CD19 Chimeric Antigen Receptor T Cell ImmunotherapyWon Lee, Jiwon Yang, Destanie Rose et al.|Blood|2023Cited by 2
In Vivo PBMC-Humanized Mouse Model to Assess Individual Variability in Efficacy and Toxicity of Autologous and Allogeneic Chimeric Antigen Receptor T-Cell ImmunotherapyWon Lee, Jiwon Yang, Destanie Rose et al.|Blood|2022Cited by 1
Abstract 4096: Assessing individual variability in efficacy and toxicity of autologous and allogeneic chimeric antigen receptor T-cell immunotherapy using a PBMC-humanized mouse modelWon Lee, Jiwon Yang, Destanie Rose et al.|Cancer Research|2023Cited by 1
Abstract 7265: Using PBMC-humanized mice to identify optimal autologous CAR T products for maximized efficacy and minimized toxicity at an individual level: a study of CD19, CD22, and CD19x22-specific constructs in multiple PBMC donorsWon Lee, Jiwon Yang, Destanie Rose et al.|Cancer Research|2025Cited by 0